60 degrees pharmaceuticals announces third quarter 2024 results

60 degrees pharma (sxtp) reported 164% revenue growth and clinical progress on arakoda® for infectious diseases and babesiosis in its 3q24 earnings report.
SXTP Ratings Summary
SXTP Quant Ranking